Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2026-01-26 @ 4:54 AM
Study NCT ID:
NCT07195227
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-10-02
First Post:
2025-06-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Camizestrant Plus Ribociclib in Patients With Breast Cancer
Sponsor:
MedSIR
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MEDOPP555
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None